EP Patent

EP3270912A1 — Pharmaceutical compositions containing taxane-cyclodextrin complexes, method of making and methods of use

Assigned to Meridian Lab · Expires 2018-01-24 · 8y expired

What this patent protects

Pharmaceutical formulations for parenteral administration comprising taxane compounds complexed with cyclodextrins and polyethylene glycol, methods of making the pharmaceutical formulations and methods of treating cancer patients using the pharmaceutical formulations.

USPTO Abstract

Pharmaceutical formulations for parenteral administration comprising taxane compounds complexed with cyclodextrins and polyethylene glycol, methods of making the pharmaceutical formulations and methods of treating cancer patients using the pharmaceutical formulations.

Drugs covered by this patent

Patent Metadata

Patent number
EP3270912A1
Jurisdiction
EP
Classification
—
Expires
2018-01-24
Drug substance claim
No
Drug product claim
No
Assignee
Meridian Lab
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.